Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2026-07-05

Alterations in the human oral and gut microbiomes and lipidomics in COVID-19

COVID-19 patients showed reduced oral and gut microbial diversity, with fewer butyric-acid-producing and more lipopolysaccharide-producing bacteria. Classifiers built on 8 oral and 7 fecal microbial markers diagnosed COVID-19 with area-under-curve values above 0.87, and diagnosed antibody-positive suspected cases.

2026-07-05

The human gut microbiome as a screening tool for colorectal cancer

Adding gut microbiome data to age, race, and body mass index sharply improved detection of colon adenomas and carcinomas; a microbiome test raised a 65-year-old's probability of harboring an adenoma from 0.17 percent to 10.67 percent, more than a 50-fold gain.